Evidence map›Paper›PMID 35393306›Full record

Observational studyBMJ open2022

Hepatitis B virus infection and factors associated with its acquisition among adults in a Lake Victoria HIV hyperendemic fishing community in Kyotera district, Uganda: a cross-sectional observation.

Charles Ssuuna, Victor Ssempijja, Sarah Kalibbala, David Serwadda, Ping Teresa Yeh, Maria Wawer, Ronald Gray, Larry Chang, Joseph Kagaayi, Steven Reynolds

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Charles SsuunaRakai Health Sciences Program, Kalisizo, Uganda cssuuna@rhsp.org.
Victor SsempijjaRakai Health Sciences Program, Kalisizo, Uganda.ORCID 0000-0003-2609-6525
Sarah KalibbalaRakai Health Sciences Program, Kalisizo, Uganda.
David SerwaddaRakai Health Sciences Program, Kalisizo, Uganda.
Ping Teresa YehInternational Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-7425-0382
Maria WawerEpidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ronald GrayEpidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Larry ChangEpidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Joseph KagaayiRakai Health Sciences Program, Kalisizo, Uganda.
Steven ReynoldsSchool of Medicine, Department of Infectious Disease, Johns Hopkins University, Baltimore, Maryland, USA.
Rakai Health Sciences Program · UGJohns Hopkins University · USNational Institutes of Health · US

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Synthesizing HIV Behavioral Intervention Effectiveness in Developing CountriesR01MH090173 · NIMH · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SWEAT, MICHAEL D · 2010 to 2019
$4.2M
CHWs, mHealth, and Combination HIV Prevention in a Hotspot: A Randomized TrialR01MH107275 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM · 2015 to 2019
$2.7M
Hard-to-Reach Populations: Implications for Ending the AIDS EpidemicR01AI143333 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM · 2019 to 2022
$2.4M
Multidisciplinary Research Training to Understand and Reduce HIV Incidence in UgandaD43TW010557 · FIC · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM · 2018 to 2022
$1.6M
CCR NIH HHS HHSN261200800001CFIC NIH HHS D43 TW010557NCI NIH HHS HHSN261200800001ENIAID NIH HHS R01 AI143333NIMH NIH HHS R01 MH090173NIMH NIH HHS R01 MH107275
6 · The paper itself

Abstract

objectiveTo investigate hepatitis B virus (HBV) prevalence and factors associated with viral acquisition in a HIV-hyperendemic fishing community, we tested sera for anti-hepatitis B core (HBc) and hepatitis B surface antigen (HBsAg).

designObservational cross-sectional study.

settingLarge fishing village on Lake Victoria, one of the HIV-hyperendemic Rakai Community Cohort Study (RCCS) sites (HIV prevalence ~40%).

participantsSample of 460 RCCS participants aged 15-49 years from survey conducted from 5 December 2016 to 13 February 2017. These proportionately included HIV-negative, HIV-positive antiretroviral therapy (ART)-naïve and HIV positive on ART participants.

resultsOf the 460 participants, 49.6% (95% CI 45.0% to 54.1%) had evidence of prior HBV infection and 3.7% (95% CI 2.3% to 5.9%) were either acutely or chronically infected. HBV risk increased with age, number of lifetime sex partners and HIV seropositivity. HBV risk decreased with HIV ART use among HIV-positive participants. Prevalence of prior HBV infection was 17.1% in participants aged 15-19 years, 43.2%, 55.3% and 70.1% in participants aged 20-39, 30-39 and 40-49 years, respectively (p<0.001). Additionally, the prevalence of prior HBV infection was 23.8% in participants with 0-1 lifetime sex partners, 43.2% and 54.8% in participants with 2-3 lifetime sex partners and 4+ lifetime sex partners, respectively (p<0.001).

conclusionsFindings from this fishing community suggest the need to provide HBV vaccination to adults at risk of sexual transmission who have not been previously immunised.

Indexed as

Hepatitis BHIV InfectionsAdultCohort StudiesCross-Sectional StudiesHepatitis B Surface AntigensHepatitis B virusHumansHuntingLakesPrevalenceUgandaHepatitis B Surface AntigenshepatologyHIV & AIDSsexual medicine

Identifiers

PMID35393306
PMCPMC8990708
OpenAlexW4223446709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.